PL366507A1 - Cephem compounds - Google Patents

Cephem compounds

Info

Publication number
PL366507A1
PL366507A1 PL02366507A PL36650702A PL366507A1 PL 366507 A1 PL366507 A1 PL 366507A1 PL 02366507 A PL02366507 A PL 02366507A PL 36650702 A PL36650702 A PL 36650702A PL 366507 A1 PL366507 A1 PL 366507A1
Authority
PL
Poland
Prior art keywords
cephem compounds
cephem
compounds
Prior art date
Application number
PL02366507A
Other languages
English (en)
Polish (pl)
Inventor
Hidenori Ohki
Shinya Okuda
Toshio Yamanaka
Takashi Ogino
Kohji Kawabata
Satoshi Inoue
Keiji Misumi
Kenji Itoh
Hisashi Akamatsu
Kenji Satoh
Original Assignee
Fujisawa Pharmaceutical Co, Ltd.
Wakunaga Pharmaceutical Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR4690A external-priority patent/AUPR469001A0/en
Priority claimed from AUPR5834A external-priority patent/AUPR583401A0/en
Application filed by Fujisawa Pharmaceutical Co, Ltd., Wakunaga Pharmaceutical Co, Ltd. filed Critical Fujisawa Pharmaceutical Co, Ltd.
Publication of PL366507A1 publication Critical patent/PL366507A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PL02366507A 2001-05-01 2002-04-24 Cephem compounds PL366507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR4690A AUPR469001A0 (en) 2001-05-01 2001-05-01 Cephem compounds
AUPR5834A AUPR583401A0 (en) 2001-06-20 2001-06-20 Cephem compounds

Publications (1)

Publication Number Publication Date
PL366507A1 true PL366507A1 (en) 2005-02-07

Family

ID=25646666

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02366507A PL366507A1 (en) 2001-05-01 2002-04-24 Cephem compounds

Country Status (19)

Country Link
US (1) US7179801B2 (enExample)
EP (1) EP1392704B1 (enExample)
JP (1) JP4251873B2 (enExample)
KR (1) KR20030090794A (enExample)
CN (1) CN1522259A (enExample)
AR (1) AR033300A1 (enExample)
AT (1) ATE318269T1 (enExample)
BR (1) BR0209452A (enExample)
CA (1) CA2446099A1 (enExample)
DE (1) DE60209341T2 (enExample)
ES (1) ES2254671T3 (enExample)
HU (1) HUP0304042A2 (enExample)
MX (1) MXPA03010002A (enExample)
NO (1) NO20034824L (enExample)
NZ (1) NZ529887A (enExample)
PL (1) PL366507A1 (enExample)
RU (1) RU2003134629A (enExample)
TW (1) TWI224599B (enExample)
WO (1) WO2002090364A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4448821B2 (ja) * 2002-10-30 2010-04-14 アステラス製薬株式会社 セフェム化合物
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE602004026451D1 (de) * 2003-09-18 2010-05-20 Astellas Pharma Inc Cephem-verbindungen
WO2005044819A1 (en) * 2003-10-28 2005-05-19 Schering Corporation Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
EP1721906A4 (en) * 2004-03-05 2008-02-27 Shionogi & Co METHYLCEPHEM COMPOUND 3-PYRIDINIUM
JP2009530228A (ja) * 2006-03-16 2009-08-27 アステラス製薬株式会社 セフェム化合物および抗菌薬としての利用
HK1200096A1 (en) 2011-09-09 2015-07-31 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104140427A (zh) * 2014-07-05 2014-11-12 湖南华腾制药有限公司 一种四氢吡唑并[1,5-a]嘧啶的制备方法
CN107922435B (zh) * 2015-09-08 2022-05-17 桑多斯股份公司 由7-氨基头孢烷酸(7-aca)制备头孢洛扎的方法
CN107586305A (zh) * 2017-06-23 2018-01-16 浙江惠迪森药业有限公司 一种β‑内酰胺类化合物羧基及羟基保护基脱除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5210080A (en) * 1987-09-07 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
IE63094B1 (en) * 1987-09-14 1995-03-22 Fujisawa Pharmaceutical Co Cephem compound and a process for preparation thereof
US5173485A (en) * 1988-03-09 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Cephem compounds
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR910015587A (ko) * 1990-02-27 1991-09-30 후지사와 토모키치로 세펨 화합물
JPH09110877A (ja) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
AUPN955596A0 (en) * 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
JP4448821B2 (ja) * 2002-10-30 2010-04-14 アステラス製薬株式会社 セフェム化合物
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE602004026451D1 (de) * 2003-09-18 2010-05-20 Astellas Pharma Inc Cephem-verbindungen

Also Published As

Publication number Publication date
AR033300A1 (es) 2003-12-10
NZ529887A (en) 2005-05-27
JP2004529172A (ja) 2004-09-24
ES2254671T3 (es) 2006-06-16
CN1522259A (zh) 2004-08-18
CA2446099A1 (en) 2002-11-14
NO20034824D0 (no) 2003-10-29
KR20030090794A (ko) 2003-11-28
WO2002090364A1 (en) 2002-11-14
TWI224599B (en) 2004-12-01
ATE318269T1 (de) 2006-03-15
EP1392704A1 (en) 2004-03-03
JP4251873B2 (ja) 2009-04-08
DE60209341T2 (de) 2006-08-03
RU2003134629A (ru) 2005-06-10
US7179801B2 (en) 2007-02-20
HUP0304042A2 (hu) 2004-04-28
MXPA03010002A (es) 2004-06-30
NO20034824L (no) 2003-12-29
DE60209341D1 (de) 2006-04-27
EP1392704B1 (en) 2006-02-22
US20040248875A1 (en) 2004-12-09
BR0209452A (pt) 2004-12-14

Similar Documents

Publication Publication Date Title
HUS1600008I1 (hu) Cefémvegyületek
AU2002349297A8 (en) Statin-like compounds
GB0101996D0 (en) Organtic compounds
GB0102668D0 (en) Compounds
GB0112324D0 (en) Compounds
PL366507A1 (en) Cephem compounds
GB0121488D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0108102D0 (en) Compounds
GB0102673D0 (en) Compounds
GB0119472D0 (en) Compounds
GB0118364D0 (en) Compounds
GB0115178D0 (en) Compounds
GB0120344D0 (en) Compounds
GB0108097D0 (en) Compounds
GB0105098D0 (en) Compounds
AUPR583401A0 (en) Cephem compounds
AUPR469001A0 (en) Cephem compounds
AU2003274754A8 (en) Cephem compounds
GB0121485D0 (en) Compounds
GB0104397D0 (en) Compounds
GB0130386D0 (en) Compounds
GB0130390D0 (en) Compounds
GB0130391D0 (en) Compounds
GB0111183D0 (en) Compounds